A5101689200- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease Diagnosis and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cancer, Lipids, and Metabolism
- Pancreatic and Hepatic Oncology Research
- Liver Disease and Transplantation
- Radiomics and Machine Learning in Medical Imaging
- Ferroptosis and cancer prognosis
- Cancer Mechanisms and Therapy
- Gallbladder and Bile Duct Disorders
- MRI in cancer diagnosis
- Drug-Induced Hepatotoxicity and Protection
- Infrared Thermography in Medicine
- Colorectal Cancer Treatments and Studies
- Gastrointestinal motility and disorders
- Intracranial Aneurysms: Treatment and Complications
- Organ Transplantation Techniques and Outcomes
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
- Cancer, Hypoxia, and Metabolism
- Contact Dermatitis and Allergies
- Genetic factors in colorectal cancer
- Rice Cultivation and Yield Improvement
- Vascular Malformations Diagnosis and Treatment
- Thyroid Cancer Diagnosis and Treatment
Eastern Hepatobiliary Surgery Hospital
2009-2025
Second Military Medical University
2010-2025
Ateliéry Tapisérií sro
2010
Background Tumor recurrence is a major problem after curative resection of hepatocellular carcinoma (HCC). The current study evaluated the effects adjuvant iodine-125 (125I) brachytherapy on postoperative HCC. Methodology/Principal Findings From July 2000 to June 2004, 68 HCC patients undergoing hepatectomy were randomly assigned into 125I group (n = 34) and best care 34). Patients in received seed implantation raw surface resection. control identical treatments except for implantation. Time...
ABSTRACT Background Hepatocellular carcinoma (HCC) is the second leading cause of cancer‐related death in China. The rapid progress systemic therapies has led to approval many therapeutic methods that have quickly changed clinical guidelines and practices. Because high heterogeneity HCC, there are still some gaps between real‐world practice. present study surveyed experts China investigate current treatment concepts practice regarding HCC. Methods A questionnaire survey on HCC was...
Abstract Background The role of anatomic resection (AR) versus non-anatomic (NAR) for intrahepatic cholangiocarcinoma (ICC) has not been thoroughly investigated. This study sought to define the impact tumor size on relative therapeutic benefit AR NAR ICC. Specifically, aimed identify a threshold when rather than may be warranted achieve better survival outcomes patients undergoing Methods Patients who underwent liver ICC were identified from an international multi-institutional database. A...
The role of adjuvant transarterial chemoembolisation (TACE) to reduce postoperative recurrence varies widely among patients undergoing hepatectomy with curative intent for hepatocellular carcinoma (HCC). Personalised predictive tool select which may benefit from TACE is lacking. This study aimed develop and validate an online calculator estimating the reduced risk early HCC. From a multi-institutional database, 2590 eligible curative-intent HCC were enrolled, randomly assigned training...